| 58.16 -3.44 (-5.58%) | 10-30 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 77.67 |
1-year : | 85.26 |
| Resists | First : | 66.5 |
Second : | 73 |
| Pivot price | 60.77 |
|||
| Supports | First : | 56 | Second : | 46.59 |
| MAs | MA(5) : | 61.17 |
MA(20) : | 61.47 |
| MA(100) : | 63.24 |
MA(250) : | 52.8  |
|
| MACD | MACD : | -1.4 |
Signal : | -1.5 |
| %K %D | K(14,3) : | 57.9 |
D(3) : | 66.7 |
| RSI | RSI(14): 38.5 |
|||
| 52-week | High : | 77 | Low : | 28.8 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ PDEX ] has closed above bottom band by 13.1%. Bollinger Bands are 38% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 63.8 - 64.23 | 64.23 - 64.58 |
| Low: | 56.92 - 57.31 | 57.31 - 57.63 |
| Close: | 57.59 - 58.22 | 58.22 - 58.74 |
Pro-Dex, Inc. focuses on the development and manufacturing of advanced motorized surgical instruments. These sophisticated tools are supplied globally to original equipment manufacturers (OEMs) in the medical device sector. Their product portfolio features versatile, autoclavable (sterilization-friendly) surgical drivers and shavers, available in both battery-powered and electric models, often equipped with multi-functional capabilities. These instruments are primarily employed in orthopedic, thoracic, and craniomaxillofacial surgical procedures. Beyond its core manufacturing, Pro-Dex also offers expert consulting services, covering engineering, quality assurance, and regulatory compliance. Furthermore, the company manufactures and distributes rotary air motors to various industrial clients. Founded in 1978, Pro-Dex, Inc. maintains its corporate headquarters in Irvine, California.
Fri, 30 Oct 2026
Pro-Dex (PDEX) unit signs a new industrial lease starting at $11,600 a month. - Stock Titan
Thu, 29 Oct 2026
Pro-Dex Inc (PDEX) Reports Q1 FY2027 Earnings: Revenue Hits $20. - GuruFocus
Thu, 29 Oct 2026
Pro-Dex (NASDAQ:PDEX) EPS Beat and Margin Expansion Offset In-Line Revenue - ChartMill
Thu, 29 Oct 2026
Pro-Dex, Inc. (PDEX) Q1 Earnings and Revenues Surpass Estimates - Yahoo Finance
Thu, 29 Oct 2026
Sales rise 11% at Pro-Dex (PDEX), but earnings move the other way. - Stock Titan
Thu, 29 Oct 2026
Pro-Dex, Inc. Announces Fiscal 2027 First Quarter Results - Corsicana Daily Sun
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 3 (M) |
| Shares Float | 2 (M) |
| Held by Insiders | 36 (%) |
| Held by Institutions | 32 (%) |
| Shares Short | 199 (K) |
| Shares Short P.Month | 179 (K) |
| EPS | 4.11 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 14.94 |
| Profit Margin | 17.6 % |
| Operating Margin | 17.2 % |
| Return on Assets (ttm) | 11.9 % |
| Return on Equity (ttm) | 32.4 % |
| Qtrly Rev. Growth | 16.6 % |
| Gross Profit (p.s.) | 7.53 |
| Sales Per Share | 24 |
| EBITDA (p.s.) | 4.45 |
| Qtrly Earnings Growth | 143.3 % |
| Operating Cash Flow | 7 (M) |
| Levered Free Cash Flow | 5 (M) |
| PE Ratio | 14.11 |
| PEG Ratio | 0 |
| Price to Book value | 3.89 |
| Price to Sales | 2.42 |
| Price to Cash Flow | 25.94 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|